Stable Istotope Labelled Abatacept Biosimilar – Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb – Research Grade

Reference: PX-TA1020-SIL-1MG
Product nameStable Istotope Labelled Abatacept Biosimilar - Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb - Research Grade
SourceDrugBank DB01281
SpeciesHuman
Expression systemMammalian cells
Molecular weight92kDa
Purity>95%
BufferPBS pH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsAbatacept
ReferencePX-TA1020-SIL
Related ProductsPX-P4018
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypehG1-Fc
ClonalityMonoclonal Antibody
SourceDrugBank DB01281
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year
FormulaC3498H5458N922O1090S32

General information about Abatacept

Abatacept est une protéine de fusion composée du domaine extracellulaire de l’antigène 4 cytotoxique humain associé au lymphocyte T (CTLA-4) lié à une partie Fc modifiée d’immunoglobuline humaine (IgG1) qui inhibe le signal de co-stimulation CD80/86 nécessaire à l’activation des lymphocytes T exprimant le CD28. This product is for research use only.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Abatacept Biosimilar – Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.